DODC

Last updated
DODC
DODC.svg
Identifiers
  • 1-(2,5-dimethoxy-3,4-dichlorophenyl)propan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
Formula C11H15Cl2NO2
Molar mass 264.15 g·mol−1
3D model (JSmol)
  • Clc1c(OC)cc(CC(C)N)c(OC)c1Cl
  • InChI=1S/C11H15Cl2NO2/c1-6(14)4-7-5-8(15-2)9(12)10(13)11(7)16-3/h5-6H,4,14H2,1-3H3
  • Key:IGOFLAWWDQNRCV-UHFFFAOYSA-N

DODC is a psychedelic drug from the substituted amphetamine family which acts as an agonist of the 5-HT2A receptor. It is the 3,4-dichloro derivative of the well known psychedelic drug 2,5-dimethoxy-4-chloroamphetamine (DOC). DODC was first officially published in a patent filed by Gilgamesh Pharmaceuticals in 2020, [1] though anecdotal reports suggest it had been synthesised by clandestine chemists and its activity established several years prior to this.

See also

References

  1. ↑ WO 2022/006186,Kruegel AC,"Phenalkylamines and Methods of Treating Mood Disorders.",published January 2022, assigned to Gilgamesh Pharmaceuticals.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.